Modelling two different therapy strategies for drug T-20 on HIV-1 patients

DOI10.1007/s10483-011-1427-8zbMath1219.92047OpenAlexW1570442575MaRDI QIDQ536537

Jie Lou, Qing-zhi Wen, Bao-jun Song

Publication date: 19 May 2011

Published in: Applied Mathematics and Mechanics. (English Edition) (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1007/s10483-011-1427-8

Mathematics Subject Classification ID

Ordinary differential equations with impulses (34A37) Medical applications (general) (92C50) Asymptotic expansions of solutions to PDEs (35C20) Applications of difference equations (39A60)

Related Items (8)

Analysis of HIV latent infection model with multiple infection stages and different drug classes ⋮ Mathematical modelling of enfuvirtide and protease inhibitors as combination therapy for HIV ⋮ Impact of combined therapy in HIV-1 treatment: a double impulsive approach ⋮ Analysis of global dynamics for HIV-infection of CD4+T cells and its treatment ⋮ An in-host HIV-1 infection model incorporating quiescent and activated \(\mathrm{CD}4^+\) T cells as well as CTL response ⋮ Anti-viral drug treatment along with immune activator IL-2: a control-based mathematical approach for HIV infection ⋮ The effect of vaccination to dendritic cell and immune cell interaction in HIV disease progression ⋮ The effects of CTL immune response on HIV infection model with potent therapy, latently infected cells and cell-to-cell viral transmission

Cites Work

• Unnamed Item
• Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects
• Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects
• The global dynamics of a model about HIV-1 infection in vivo
• The threshold of survival for systems in a fluctuating environment
• Dynamics of HIV infection of CD4\(^ +\) T cells
• A model of HIV-1 pathogenesis that includes an intracellular delay
• Mathematical Analysis of HIV-1 Dynamics in Vivo

This page was built for publication: Modelling two different therapy strategies for drug T-20 on HIV-1 patients